Global perspectives on addictions and drug markets

In programme
23 sessions 112 presentations View the programme

About

This track is co-produced by Inter·GLAM (I·G). I·G is a European project, co-funded by DG JUST at the European Commission, running from July 2021 to June 2023

  • Global issues: how are socio-demographic, technological, political, environmental and other global challenges impacting on substance use, associated problems and markets?
  • New market challenges: market flows, novel and new psychoactive substances and medicinal products.
  • Drug use, lifestyles and settings: socio-cultural contexts and physical environments, voices from impacted communities.
  • Recognising global diversity in public health responses; putting evidence into practice in different cultures and settings (translational aspects and transferability).
  • Impact of the global public health crisis on the addictions field.

 

Sessions

Wednesday, 23 November

10:50

Drug policy: socio-political influence, cultural diversity

10:50 to 12:20
Insights zone 1 (I1)
InterGLAM cinema

Addressing substance use and substance use disorders in humanitarian settings: the role of evidence-based prevention, treatment and care

10:50 to 12:20
Insights zone 4 (I4)
Structured session
13:20

Drug use in diverse communities and settings

13:20 to 14:50
Networking zone 1 (N1)
e-poster guided tour

Migration, substance use and interventions in Europe

13:20 to 14:50
Insights zone 4 (I4)
Structured session
15:00

How prepared are monitoring systems to respond to rapidly changing drug markets in regions bordering the European Union?

15:00 to 16:30
Insights zone 4 (I4)
Structured session

Surveillance

15:00 to 16:30
Networking zone 4 (N4)
Short communication session
InterGLAM video session

The breadth of global addiction experiences

15:00 to 16:30
Insights zone 1 (I1)
InterGLAM cinema
16:50

Economic recessions, COVID-19, socio-determinants of drug use and its harms: deaths of despair?

16:50 to 18:20
Central square 4 (C4)
Workshop

Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market

16:50 to 18:20
Insights zone 4 (I4)
Structured session

Thursday, 24 November

10:50

Current international evidence on prevalence and perceptions of Heated Tobacco Products (HTPs)

10:50 to 12:20
Insights zone 4 (I4)
Structured session

Media Representations and depictions of drug use, addiction and drug markets

10:50 to 12:20
Insights zone 1 (I1)
InterGLAM cinema
13:20

Diversity, stigma, and vulnerability

13:20 to 14:50
Networking zone 4 (N4)
Short communication session

New Psychoactive Substances

13:20 to 14:50
Insights zone 4 (I4)
Oral presentation session

Shifting markets and drug trafficking

13:20 to 14:50
Networking zone 2 (N2)
e-poster guided tour

The globalised illicit drug market

13:20 to 14:50
Main stage
Structured session
15:00
InterGLAM video session

Policy and practice to tackle addictions around the world

15:00 to 16:30
Insights zone 1 (I1)
InterGLAM cinema

The implementation and evaluation of “safer supply” programs in Canada as a response to an ongoing overdose crisis

15:00 to 16:30
Insights zone 4 (I4)
Structured session
16:50
InterGLAM video session

Different approaches for different populations

16:50 to 18:20
Insights zone 1 (I1)
InterGLAM cinema

How to develop global surveys, guidelines, checklists and consensus statements in prevention and treatment of addiction: new innovations in the pandemic era

16:50 to 18:20
Insights zone 4 (I4)
Structured session

Friday, 25 November

10:50

Global Issues - Backcasting exercise

10:50 to 12:20
Insights zone 1 (I1)
InterGLAM cinema

COVID-19-adapted addiction services and impact for service users

10:50 to 12:20
Insights zone 4 (I4)
Structured session
13:20

Changes and trends in how people are buying drugs

13:20 to 14:50
Insights zone 4 (I4)
Oral presentation session

InterGLAM Video Contest Award Ceremony

13:20 to 14:50
Insights zone 1 (I1)
InterGLAM cinema

Presentations

Wednesday, 23 November

10:50
Oral presentation

5. Addressing substance use and related problems in reception settings in Europe

10:50 to 12:20
Insights zone 4 (I4)
Charlotte De Kock, Klaudia Palczak
Oral presentation

6. Caregiving packages in conflict and humanitarian settings for prevention of substance use and other health and social consequences and for child protection and development

10:50 to 12:20
Insights zone 4 (I4)
Wadih Maalouf
Oral presentation

7. Understanding and Responding to Substance Use and Abuse in the Palestinian Refugee Camps inLebanon Prior to and During COVID-19 Times

10:50 to 12:20
Insights zone 4 (I4)
Marie Claire Van Hout
Oral presentation

3. Handbook on Addressing Substance Use Disorders in Humanitarian Settings – Access to Services for Displaced Populations and Host Communities in Acute and Protracted Emergencies

10:50 to 12:20
Insights zone 4 (I4)
Anja Busse
Oral presentation

1. Priorities for addressing substance use disorder in humanitarian settings

10:50 to 12:20
Insights zone 4 (I4)
M. Claire Greene
Oral presentation

2. Substance Use Among Populations Displaced by Conflict: Assessments, Findings, Recommendations

10:50 to 12:20
Insights zone 4 (I4)
Nadine Ezard
Oral presentation

1. Gender-sensitive drug policy

10:50 to 12:20
Insights zone 1 (I1)
Gabriele Fischer
Oral presentation

2. Youth-centered drug policy

10:50 to 12:20
Insights zone 1 (I1)
Danya Fast
Oral presentation

3. Perspectives of people who use drugs on drug policy

10:50 to 12:20
Insights zone 1 (I1)
Mat Southwell
Introduction

Drug policy: socio-political influence, cultural diversity

10:50 to 12:20
Insights zone 1 (I1)
Abhishek Ghosh
13:20
e-poster

A retrospective overview of polydrug abuse in Tunisia

13:20 to 14:50
Networking zone 1 (N1)
Bilel Moslah
e-poster

Professionals’ views on challenges in inpatient substance abuse treatment during COVID-19 pandemic

13:20 to 14:50
Networking zone 1 (N1)
Eeva Ekqvist
e-poster

Tipping points surrounding motivation to change substance use patterns among seniors in the general population or with incarceration experience: are they all the same?

13:20 to 14:50
Networking zone 1 (N1)
Valérie Aubut
e-poster

Methodological challenges and policy relevance of studies on substance use in nightlife settings: the case of the Nightlife Study in the Netherlands

13:20 to 14:50
Networking zone 1 (N1)
Karin Monshouwer
e-poster

COVID-19 related stressors and alcohol use among urban refugee youth in Kampala, Uganda

13:20 to 14:50
Networking zone 1 (N1)
Carmen Logie
Oral presentation

4. The Impact of the Russian Invasion of Ukraine on Needle and Syringe Distribution by Harm Reduction Organizations

13:20 to 14:50
Insights zone 4 (I4)
Benjamin Nikitin
e-poster

Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon

13:20 to 14:50
Networking zone 1 (N1)
Joana Canedo
Oral presentation

1. Equitable substance use treatment for migrants, refugees and ethnic minorities: An emerging research domain

13:20 to 14:50
Insights zone 4 (I4)
Inês Hasselberg
Oral presentation

2. Substance use disorders in refugee and migrant groups in Sweden: A nationwide cohort study of 1.2 million people

13:20 to 14:50
Insights zone 4 (I4)
Samantha Harris
Oral presentation

5. Services for vulnerable Migrants who use Drugs in the EU (SEMID-EU)

13:20 to 14:50
Insights zone 4 (I4)
Machteld Busz
Discussion

Ways forward: synthetizing priorities in prevalence studies and intervention needs in the EU

13:20 to 14:50
Insights zone 4 (I4)
Charlotte De Kock, Klaudia Palczak
Oral presentation

3. Smartphone-based addiction prevention for young refugees: results of a feasibility study

13:20 to 14:50
Insights zone 4 (I4)
Lina-Sophia Falkenberg
e-poster

Cannabis use and aquisition in pandemic times – results from a sample of regular users in Germany

13:20 to 14:50
Networking zone 1 (N1)
Bernd Werse
15:00
Short communication

A longitudinal study of a drug checking service for patrons of Boom Festival 2018: behavioral outcomes at individual and group levels.

15:00 to 16:30
Networking zone 4 (N4)
Helena Valente
Oral presentation

3. Key developments in drug markets of Western Balkans

15:00 to 16:30
Insights zone 4 (I4)
Robert Patrancus, Katerina Skarupova
Oral presentation

5. Changing drug market requires new priorities for Moldova’s law enforcement authorities

15:00 to 16:30
Insights zone 4 (I4)
Vladislav Cojuhari
Oral presentation

2. Lebanon: responding to drug market changes in crisis situation

15:00 to 16:30
Insights zone 4 (I4)
Zeinab Abbas
Oral presentation

4. Key developments in drug markets of Eastern European Neighbourhood Policy (ENP) countries

15:00 to 16:30
Insights zone 4 (I4)
Daan Van der Gouwe
Short communication

Findings from novel methods of surveillance for fentanyl and novel psychoactive substances within Supervised Injecting Facilities

15:00 to 16:30
Networking zone 4 (N4)
Suzanne Nielsen
Short communication

Detection of Potent 'Nitazene' Synthetic Opioids by a networked drug checking service in Toronto, Ontario, Canada

15:00 to 16:30
Networking zone 4 (N4)
Kristy Scarfone
Short communication

Method development for monitoring Google-indexed e-shops offering new psychoactive substances (NPS) in The Netherlands.

15:00 to 16:30
Networking zone 4 (N4)
Lavinia Stegemann
Short communication

How to evaluate complex drug policies? A case study of the Belgian drug policy

15:00 to 16:30
Networking zone 4 (N4)
Eva Blomme
Short communication

The Unit of Cannabis: from a systematic review to a NIDA recommendation

15:00 to 16:30
Networking zone 4 (N4)
María Teresa Pons-cabrera
Oral presentation

1. Key developments in drug markets of North Africa and Middle East

15:00 to 16:30
Insights zone 4 (I4)
Emadeddin Badi
Video

6. These walls by heart

15:00 to 16:30
Insights zone 1 (I1)
Video

2. SUMAYA

15:00 to 16:30
Insights zone 1 (I1)
Video

3. A trip through Kosmicare's drug checking service

15:00 to 16:30
Insights zone 1 (I1)
Video

4. Inside drug users (in)visibilities

15:00 to 16:30
Insights zone 1 (I1)
Video

5. The Click

15:00 to 16:30
Insights zone 1 (I1)
Video

1. Connecting with Care – Toronto

15:00 to 16:30
Insights zone 1 (I1)
16:50
Oral presentation

1. The Impact of Economic Recessions on the Use of Illicit Drugs: a Systematic Review of Literature and a Meta-Analysis

16:50 to 18:20
Central square 4 (C4)
Claudia Costa Storti
Oral presentation

2. The impact of economic recessions on the harms of drug use and health responses, in Europe: a panel data analysis

16:50 to 18:20
Central square 4 (C4)
Bruno Casal
Oral presentation

3. Structural vulnerabilities and deaths of despair in Scotland, 1980-2021

16:50 to 18:20
Central square 4 (C4)
Mirjam Allik
Discussion

What lessons have we learn from past that apply to the COVID-19 induced recession? A structured debate

16:50 to 18:20
Central square 4 (C4)
Liesbeth Vandam
Oral presentation

1. Analysis of NPS and drugs purchased on Darknet and Clearnet markets

16:50 to 18:20
Insights zone 4 (I4)
Mireia Ventura
Oral presentation

2. The influence of legislation on the availability of NPS

16:50 to 18:20
Insights zone 4 (I4)
Judith Aldridge
Oral presentation

3. Prevalence of NPS use. Results of the implementation of a standardized survey methodology amongst 25 civil society organization in Europe

16:50 to 18:20
Insights zone 4 (I4)
Jochen Schrooten
Discussion

The importance of the justice programme

16:50 to 18:20
Insights zone 4 (I4)
Koralia Kontou
Introduction

Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market

16:50 to 18:20
Insights zone 4 (I4)
Margot Balcaen

Thursday, 24 November

10:50
Oral presentation

1. Global Prevalence of Heated Tobacco Product Use: A Systematic Review and Meta-analysis

10:50 to 12:20
Insights zone 4 (I4)
Tianze Sun
Oral presentation

2. HTP prevalence in England and use for smoking cessation

10:50 to 12:20
Insights zone 4 (I4)
Harry Tattan-Birch
Oral presentation

3. Perceived health risks of heated tobacco products, tobacco cigarettes, and e-cigarettes: Findings from a populationbased cross-sectional household survey in Germany (DEBRA study)

10:50 to 12:20
Insights zone 4 (I4)
Stephanie Klosterhalfen
Oral presentation

4. Harm perceptions of heated tobacco products and vaping among students at Lithuanian universities

10:50 to 12:20
Insights zone 4 (I4)
Erikas Simonavičius
Oral presentation

5. It’s not what you’d term normal smoking’: A qualitative exploration of HTP user identity

10:50 to 12:20
Insights zone 4 (I4)
Katherine A. East
Oral presentation

1. Representations of narcoculture

10:50 to 12:20
Insights zone 1 (I1)
América Tonantzin Becerra Romero
Oral presentation

2. Journalism and illegal drugs, a complex relationship

10:50 to 12:20
Insights zone 1 (I1)
Daniel Font Noguerol
Oral presentation

3. Harm reduction and addiction in social media. How to do it right?

10:50 to 12:20
Insights zone 1 (I1)
Damian Sobczyk
Oral presentation

4. ACEs to Assets

10:50 to 12:20
Insights zone 1 (I1)
Dave Higham
13:20
Oral presentation

Codesigning an Australian National Prompt Response Network for Emerging Drugs

13:20 to 14:50
Insights zone 4 (I4)
Penelope Hill
Short communication

Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada

13:20 to 14:50
Networking zone 4 (N4)
Taylor Fleming
Oral presentation

A qualitative study of people who use new psychoactive substances and harm reduction services in eight countries of Eastern Europe and Central Asia region

13:20 to 14:50
Insights zone 4 (I4)
Eliza Kurcevič
Short communication

Trends and factors associated with illicit drug use and HIV outcomes in South Africa: findings from multiple national population-based household surveys

13:20 to 14:50
Networking zone 4 (N4)
Kennedy Kipkoech
Oral presentation

In vitro pharmacological characterization of recent non-fentanyl synthetic opioids including 2-benzylbenzimidazole ‘nitazene’ opioids

13:20 to 14:50
Insights zone 4 (I4)
Marthe Vandeputte
Short communication

Perceived Impact of Storytelling on Substance Use Self-Stigma

13:20 to 14:50
Networking zone 4 (N4)
Glenn Sterner
Oral presentation

Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services

13:20 to 14:50
Insights zone 4 (I4)
Pieter E. Oomen
Short communication

Social attitudes towards drug users in the context of perceptions of other marginalised social groups, based on the NSAPH 2019 Survey

13:20 to 14:50
Networking zone 4 (N4)
Katalin Felvinczi
Short communication

Cannabis engagement in Riga, Latvia: Voices from impacted communities

13:20 to 14:50
Networking zone 4 (N4)
Kristiana Bebre
e-poster

Exploring the possible human security impact of introducing Blockchain Technologies in Health Canada’s Cannabis supply chain.

13:20 to 14:50
Networking zone 2 (N2)
Stephen Johnson
e-poster

Monitoring online drug markets - The darknet project in Zurich

13:20 to 14:50
Networking zone 2 (N2)
Joël Bellmont
e-poster

Synthetic drug production and trafficking in Belgium

13:20 to 14:50
Networking zone 2 (N2)
Sophia De Seranno
e-poster

Nicotine content, labelling and flavours of e-liquids in Canada: a scan of the online retail market from 2020-2021

13:20 to 14:50
Networking zone 2 (N2)
Kimberly D'Mello
e-poster

How tiny Albania became the continent’s drug trafficking headquarters. What is the best prevention policy?

13:20 to 14:50
Networking zone 2 (N2)
Sonila Bitri
Short communication

SHIFT + Parent Training - An Intervention for Mothers and Fathers Using Illicit Drugs'

13:20 to 14:50
Networking zone 4 (N4)
Diana Moesgen
Oral presentation

The added value of drug checking data in combination with data from online drug monitoring to evaluate NPS market dynamics: the case of 3-MMC in the Netherlands.

13:20 to 14:50
Insights zone 4 (I4)
Laura Smit-rigter
Short communication

Under-reporting of meth/amphetamine use in Australia following negative media coverage

13:20 to 14:50
Networking zone 4 (N4)
Daniel Stjepanovic
Short communication

Treatment of drug use disorders in Central Asia, China, and Germany – what is the state of the art?

13:20 to 14:50
Networking zone 4 (N4)
Ingo Ilja Michels
Oral presentation

1. How Robust and Innovative are Illegal Drug Markets?

13:20 to 14:50
Main stage
Peter H. Reuter
Oral presentation

2. To what extent can drug violence indicators tell us something about underlying drug market activity?

13:20 to 14:50
Main stage
Marieke Liem
Oral presentation

4. The geography of drug markets and hotspots of violence

13:20 to 14:50
Main stage
Tuesday Reitano

3. Drug Markets in Afghanistan

13:20 to 14:50
Main stage
David Mansfield
15:00
Oral presentation

1. Why people who use drugs need a safe regulated supply of all drugs

15:00 to 16:30
Insights zone 4 (I4)
Natasha Touesnard, Matthew Alexander Bonn
Oral presentation

3. A mixed methods evaluation of risk mitigation measures to address the dual public health crisis of COVID-19 and overdose

15:00 to 16:30
Insights zone 4 (I4)
Karen Urbanoski, Bernie Pauly
Oral presentation

4. A sea of need – Safe opioid supply service provider accounts of implementing admission priorities

15:00 to 16:30
Insights zone 4 (I4)
Carol Strike
Oral presentation

5. Modeling safer supply programs: a qualitative evaluation of three safer opioid supply program models in British Columbia, Canada

15:00 to 16:30
Insights zone 4 (I4)
Andrew Ivsins, Geoff Bardwell
Oral presentation

2. Implementation of safe supply alternatives during intersecting COVID-19 and overdose health emergencies in British Columbia, Canada, 2021

15:00 to 16:30
Insights zone 4 (I4)
Allison Barker
Video

1. Equitable Drug Treatment for Migrants and Ethnic Minorities

15:00 to 16:30
Insights zone 1 (I1)
Video

2. Connecting with Care – South Africa

15:00 to 16:30
Insights zone 1 (I1)
Video

3. Prevention of overdose deaths in northern border of Mexico, Tijuana

15:00 to 16:30
Insights zone 1 (I1)
Video

4. REITOX: a model European network bridging science, policy and practice

15:00 to 16:30
Insights zone 1 (I1)
Video

5. While the situation lasts

15:00 to 16:30
Insights zone 1 (I1)
Video

6. The impact of economic recessions on the use of cannabis among young people

15:00 to 16:30
Insights zone 1 (I1)
16:50
Oral presentation

2. Cognitive Training and Rehabilitation Approaches for Addiction: A Delphi Consensus

16:50 to 18:20
Insights zone 4 (I4)
Hamed Ekhtiari
Oral presentation

3. A Methodological Checklist for fMRI Cue Reactivity Studies in Addictions: Development and Expert Consensus

16:50 to 18:20
Insights zone 4 (I4)
Antonio Verdejo-Garcia
Oral presentation

4. Translating Neuroscience into Addiction Prevention: A Delphi Consensus Study

16:50 to 18:20
Insights zone 4 (I4)
Tara Rezapour
Oral presentation

5. Global Experts-centered Consensus Development; A Series of Methodologies for Extending Harmonization and Global Representativeness in Addiction Science

16:50 to 18:20
Insights zone 4 (I4)
Arash Khojasteh Zonoozi
Discussion

How to Expand Expert-centered Methodologies within Various Areas of Addiction Science in a Global Level? A Discussion on First-hand Experiences in the Field and the Opportunities and Challenges on the Road Ahead

16:50 to 18:20
Insights zone 4 (I4)
Hamed Ekhtiari, Marc N. Potenza
Oral presentation

1. Drug Market and Use Changes During the COVID-19 Pandemic: A Global Survey

16:50 to 18:20
Insights zone 4 (I4)
Alexander Baldacchino
Video

1. Connecting with Care – Ahtahkakoop

16:50 to 18:20
Insights zone 1 (I1)
Video

2. Steroidelab: Using a social media campaign to reach anabolic steroid users in need of treatment

16:50 to 18:20
Insights zone 1 (I1)
Video

3. The Workshop of Life

16:50 to 18:20
Insights zone 1 (I1)
Video

4. Between us

16:50 to 18:20
Insights zone 1 (I1)
Video

5. The Addicted

16:50 to 18:20
Insights zone 1 (I1)
Video

6. The PriSUD-project - an explainer

16:50 to 18:20
Insights zone 1 (I1)

Friday, 25 November

10:50
Oral presentation

3. Will they accept the vaccine? A 2021 COVID-19 survey among 477 people who use drugs in Norway

10:50 to 12:20
Insights zone 4 (I4)
Gabrielle K. Welle-Strand
Oral presentation

1. Revised service delivery of opioid agonist treatment in Norway in 2021, the second year of the pandemic: a national cross-sectional study of treatment provider experiences

10:50 to 12:20
Insights zone 4 (I4)
Anne Berit Bech
Oral presentation

4. Have predictors of drug addiction relapse changed during the COVID-19 pandemic? A prospective study of recovery pathways in the Netherlands, Belgium and UK

10:50 to 12:20
Insights zone 4 (I4)
Thomas Martinelli
Oral presentation

5. The impacts of COVID-19 pandemic on drug purchasing behaviours of people who use methamphetamine in Victoria, Melbourne.

10:50 to 12:20
Insights zone 4 (I4)
Kasun Rathnayake
Oral presentation

2. A rapid assessment of take-home naloxone provision during COVID-19 in Europe

10:50 to 12:20
Insights zone 4 (I4)
Rebecca Mc Donald
Oral presentation

Optimising digital tools for substance use and substance use disorders by 2030: a backcasting exercise

10:50 to 12:20
Insights zone 1 (I1)
Elsa Caballeria, AbuTaher AbuTaher, Florian Scheibein
13:20
Oral presentation

Monitoring online illicit drug market during the COVID-19 in Georgia

13:20 to 14:50
Insights zone 4 (I4)
Irma Kirtadze
Oral presentation

Who buys drugs using online sources in Ireland? Findings from the European Web Survey on Drugs

13:20 to 14:50
Insights zone 4 (I4)
Deirdre Mongan
Oral presentation

Brokered Illegal Drug Sales as a Measure of Local Demand

13:20 to 14:50
Insights zone 4 (I4)
Georgiy Bobashev
View all tracks